Quantitative assessment of cardiac ¹²³ iodo-metaiodobenzylguanidine SPECT/CT in patients with arrhythmogenic right ventricular cardiomyopathy: Novel insight in disease monitoring.

Autor: Hagen JM; Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich 81377, Germany., Zacherl MJ; Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich 81377, Germany., Brendel M; Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich 81377, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Clauß S; Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität, Marchioninistrasse 15, 81377 Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany; Institute of Surgical Research at the Walter-Brendel-Center of Experimental Medicine, University Hospital, LMU Munich, Marchioninistrasse 27, D-81377 Munich, Germany; Member of the European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), the Netherlands; Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany., Kääb S; Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität, Marchioninistrasse 15, 81377 Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany; Institute of Surgical Research at the Walter-Brendel-Center of Experimental Medicine, University Hospital, LMU Munich, Marchioninistrasse 27, D-81377 Munich, Germany; Member of the European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), the Netherlands; Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany., Bartenstein P; Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich 81377, Germany., Todica A; Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich 81377, Germany., Böning G; Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich 81377, Germany., Fischer M; Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität, Marchioninistrasse 15, 81377 Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: Maximilian.Fischer@med.uni-muenchen.de.

Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2024 Sep; Vol. 39, pp. 101911. Date of Electronic Publication: 2024 Jul 14.

PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer.

Autor: Sheikh GT; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Gabriel.Sheikh@med.uni-muenchen.de., Trapp C; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany., Schmidt-Hegemann NS; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany., Buchner A; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany., Stief CG; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany., Unterrainer M; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Kunz WG; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Cyran CC; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Grawe F; German Cancer Research Center (DKFZ), Hector Cancer Institute at the University Medical Center Mannheim, Heidelberg, Germany.; Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Delker A; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Zacherl MJ; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Holzgreve A; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Unterrainer LM; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, USA., Brendel M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Belka C; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Li M; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany., Rogowski P; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Publikováno v: EJNMMI reports [EJNMMI Rep] 2024 Aug 19; Vol. 8 (1), pp. 25. Date of Electronic Publication: 2024 Aug 19.

Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT.

Autor: Ingenerf M; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: maria.ingenerf@med.uni-muenchen.de., Grawe F; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany; Department of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany., Winkelmann M; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany., Karim H; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany., Ruebenthaler J; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany; Interdisciplinary Centre of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), University Hospital, LMU Munich, 81377 Munich, Germany., Fabritius MP; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany., Ricke J; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany; Interdisciplinary Centre of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), University Hospital, LMU Munich, 81377 Munich, Germany., Seidensticker R; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany., Auernhammer CJ; Department of Internal Medicine 4, University Hospital, LMU Munich, 81377 Munich, Germany; Interdisciplinary Centre of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), University Hospital, LMU Munich, 81377 Munich, Germany., Zacherl MJ; Department of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany., Seidensticker M; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany; Interdisciplinary Centre of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), University Hospital, LMU Munich, 81377 Munich, Germany., Schmid-Tannwald C; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany; Interdisciplinary Centre of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), University Hospital, LMU Munich, 81377 Munich, Germany.

Publikováno v: Diagnostic and interventional imaging [Diagn Interv Imaging] 2024 Jan; Vol. 105 (1), pp. 15-25. Date of Electronic Publication: 2023 Jul 13.

The assessment of left ventricular volume and function in gated small animal ¹⁸ F-FDG PET/CT imaging: a comparative study of three commercially available software tools.

Autor: Zacherl MJ; Department of Nuclear Medicine, Ludwig-Maximilians-University, 81377, Munich, Germany., Simenhandra A; Department of Cardiology, Medical Clinic and Polyclinic I, University Hospital Munich, Marchioninistraße 15, 81377, Munich, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80336802, Munich, Germany., Lindner M; Department of Nuclear Medicine, Ludwig-Maximilians-University, 81377, Munich, Germany., Bartenstein P; Department of Nuclear Medicine, Ludwig-Maximilians-University, 81377, Munich, Germany., Todica A; Department of Nuclear Medicine, Ludwig-Maximilians-University, 81377, Munich, Germany., Boening G; Department of Nuclear Medicine, Ludwig-Maximilians-University, 81377, Munich, Germany., Fischer M; Department of Cardiology, Medical Clinic and Polyclinic I, University Hospital Munich, Marchioninistraße 15, 81377, Munich, Germany. Maximilian.Fischer@med.uni-muenchen.de.; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80336802, Munich, Germany. Maximilian.Fischer@med.uni-muenchen.de.

Publikováno v: EJNMMI research [EJNMMI Res] 2023 Aug 12; Vol. 13 (1), pp. 75. Date of Electronic Publication: 2023 Aug 12.

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [ ¹⁸ F]SiTATE.

Autor: Eschbach RS; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Hofmann M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Späth L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Sheikh GT; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Delker A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Lindner S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Jurkschat K; Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund, Dortmund, Germany., Wängler C; Biomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany., Wängler B; Medical Faculty Mannheim of Heidelberg University, Molecular Imaging and Radiochemistry, Clinic of Radiology and Nuclear Medicine, Mannheim, Germany., Schirrmacher R; Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, AB, Canada., Tiling R; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Wenter V; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Dekorsy FJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Zacherl MJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Todica A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany., Ilhan H; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany., Grawe F; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Cyran CC; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Rübenthaler J; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Knösel T; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany.; Institute of Pathology, LMU, Munich, Germany., Paul T; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany.; Institute of Pathology, LMU, Munich, Germany., Boeck S; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany.; Department of Internal Medicine 3, University Hospital, Munich, Germany., Westphalen CB; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany.; Department of Internal Medicine 3, University Hospital, Munich, Germany., Spitzweg C; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany.; Department of Internal Medicine 4, University Hospital, LMU Munich, Munich, Germany., Auernhammer CJ; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany.; Department of Internal Medicine 4, University Hospital, LMU Munich, Munich, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany., Unterrainer LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Beyer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Jan 30; Vol. 13, pp. 992316. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023).